RemeGen recently announced the closing of approximately USD $100 million in a private financing co-led by Lil...
Rgenta Therapeutics, a new biotechnology company focusing on developing RNA-targeting medicines for historical...
HBO offers free access to key series, movies HBO (NYSE:T) is responding to the burst in video streaming by of...
Cowen bullish on Amarin, sees potential $20/share In a note, Cowen's Ken Cacciatore (Outperform/$8) says Amar...
Seneca Biopharma, Inc. Announces the Completion of Stem Cell Manufacturing Facility in China
Healthcare Roundup –Global COVID-19 cases top 1M, FDA announces initiatives for antibody blood products for COVID-19
Technology Roundup – Amazon postponing Prime Day, Lyft offers free scooter rides for frontline workers
RemeGen Completes USD $100 Million Plus in Funding
The outbreak of a novel coronavirus in China, which has resulted in citywide lockdowns affecting millions of peopl...
Samsung Bioepis, a biosimilar JV formed by Korea's Samsung and US-based Biogen, will start a China P...
China has developed convalescent plasma to treat patients who are infected with the novel coronavirus (COVID-19), ...
China approved Tecentriq, an innovative anti-cancer drug developed by pharmaceutical giant Roche Holding, for its ...
The Agreement has the potential to generate up to $16MMi in gross revenue for Nextleaf Labs over the next 12 months. VANCOUVER, April 2, 2020 /CNW/ – Nextleaf Solutions Ltd. (“Nextleaf Solutions“, “OILS“, or the “Company“) (CSE: OILS) (...
The Plan will allow employees to receive equity compensation and align long-term incentives across the Company Vancouver, British Columbia--(Newsfile Corp. - April 1, 2020) - Nextleaf Solutions Ltd. (CSE: OILS) ("Nextleaf", "OILS", or the "Company"),...
Vancouver, British Columbia - TheNewswire - Apri1 1, 2020 - Naturally Splendid Enterprises Ltd. ("Naturally Splendid", "NSE" or "the Company") (FRANKFURT:50N) (TSXV:NSP) (OTC:NSPDF) is pleased to announce it has engaged AMZing Marketing Consulting to...
